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Chitinophaga terrae   
Bacteremia in  
Human
To the Editor: The genus Chitin-
ophaga, first described by Sangkhobol 
and Skerman in 1981, belongs to the 
phylum  Bacteroidetes  (formerly  the 
Cytophaga-Flexibacter-Bacteroides 
group),  which  includes  filamentous, 
chitinolytic,  gliding  bacteria  that 
transform into spherical bodies upon 
aging (1). This genus contains 10 en-
vironmental species that demonstrate 
similarities  in  16S  rDNA  sequence 
and  in  phenotypic  and  chemotaxo-
nomic data (menaquinone, fatty acids, 
hydroxy  fatty  acid,  and  polyamine) 
(2–5). Chitinophaga terrae, original-
ly isolated from soil in South Korea, 
was first described in 2007 (3,4). Here 
we report a case of bacteremia due to 
C.  terrae  in  a  severely  immunosup-
pressed woman.
On July 31, 2008, a 51-year-old 
woman was admitted to the emergen-
cy  department  at  Nantes  University 
Hospital in Nantes, France, because of 
a slowly growing left cheek mass as-
sociated with weight loss and change 
of general state. Physical examination 
showed  several  cutaneous  infiltrated 
nodules,  bilateral  axillary  adenopa-
thies, and hepatosplenomegaly. Dete-
riorating  renal  function  led  to  inter-
mittent hemodialysis. Histopathology 
of skin and renal biopsies revealed a 
diffuse, high–grade, large B-cell lym-
phoma  with  cutaneous  localization. 
Systemic  CHOP  (cyclophosphamide, 
doxorubicin,  vincristine,  prednisone) 
chemotherapy  and  methotrexate  in-
trathecal  chemotherapy  were  begun 
August 9. She developed bone marrow 
aplasia 3 days later, shortly followed 
by the onset of pyrexia. Corynebacte-
rium pseudotuberculosis was isolated 
from 3 blood samples, 2 drawn using 
the central venous catheter (CVC) and 
1 from peripheral blood. Consecutive-
ly, serotype O1 Pseudomonas aerugi-
nosa strain was isolated from cultures 
of urine and fecal specimens. The em-
pirical  antimicrobial  drug  treatment 
started  with  piperacillin-tazobactam, 
ciprofloxacin,  and  teicoplanin  on 
August 16 and was replaced by imi-
penem,  ciprofloxacin,  and  teicopla-
nin on August 21. On August 26, the 
patient  was  admitted  to  the  medical 
intensive care unit (MICU) after indi-
cations of toxic epidermal necrolysis. 
Blood analysis showed pancytopenia 
with thrombocytopenia (26 × 109/L), 
anemia  (hemoglobin  8.7  g/dL),  and 
profound  leukopenia  (0.01  ×  109/L). 
Antimicrobial  drug  treatment  was 
changed to an association of noncy-
totoxic  drugs,  i.e.,  aztreonam,  ami-
kacin,  and  teicoplanin.  Despite  this 
broad-spectrum antimicrobial therapy, 
4 aerobic blood cultures (1 drawn Au-
gust 29, 2 on September 2, and 1 on 
September 3), 2 drawn using the CVC 
and 2 from a peripheral site, yielded 
gram-negative bacilli (our laboratory 
reference no. NTS8639) after 2 days’ 
incubation.  The  CVC  was  removed 
September 3 and sent to the laboratory 
for culture. The catheter tip was im-
mersed in 2 mL of brain heart infusion 
agar, and semiquantitative culture was 
performed on the blood agar plate us-
ing 100 µL of the solution. The culture 
remained negative.
On  September  2,  treatment  was 
changed to imipenem, trimethoprim-
sulfamethoxazole,  and  teicoplanin. 
Additionally,  diagnosis  of  invasive 
pulmonary aspergillosis led to chang-
ing caspofungin prophylaxis to vori-
conazole. Trimethoprim-sulfamethox-
azole treatment was stopped September 
9,  and  imipenem  was  stopped  Sep-
tember 25, a week after bone marrow 
recovery. The patient was discharged 
from MICU on October 7.
Yellow-pigmented colonies grew 
on  bromocresol  purple  lactose  agar 
plate  after  48  hours  of  incubation 
at 37°C and appeared as thin gram-
negative  bacilli  after  gram-staining 
was  performed.  The  nonfermenting, 
nonmotile,  oxidase-positive  bacte-
rium could grow at various pH values 
(pH 6.0, 7.3, and 8.0) and at differ-
ent temperatures (30, 37, and 40°C). 
The semi-automatic Api 20NE gallery 
(bioMérieux, Marcy l’Etoile, France) 
identified the strain as Sphingomonas 
paucimobilis,  whereas  the  ID-GNB 
card  of  the  VITEK  2  system  (bio-
Mérieux) identified the bacterium as 
Sphingobacterium thalpophilum. The 
16S rDNA amplification and sequenc-
ing  were  performed  with  universal 
primers 27f and 1378r as previously 
described (6). The 1366-bp sequence 
matched that of C. terrae with 100% 
similarity, according to BIBI (Bioin-
formatic Bacteria Identification, http://
umr5558-sud-str1.univ-lyon1.fr/leb-
ibi/lebibi.cgi) or BLAST (www.ncbi.
nlm.nih.gov)  analysis.  Phylogenetic 
analysis with either the neighbor-join-
ing or maximum-parsimony algorithm 
embedded the NTS8639 strain to the 
genus  Chitinophaga  and  the  species 
C.  terrae  (Figure).  The  biochemical 
characteristics of the bacterium corre-
sponded to those previously described 
for  C.  terrae  by  Kim  and  Jung  (3). 
The  strain  reduced  nitrate  to  nitrite, 
produced  N-acetyl-β-glucosamidase, 
phosphatase, α- and β-galactosidases, 
α- and β-glucosidases, and assimilated 
l-arabinose, l-fucose, d-glucose, malt-
ose, d-mannose, d-melibiose, l-rham-
nose,  sucrose,  and  salicin  with  Api 
20NE, Api ID32GN (bioMérieux), and 
ID-GNB biochemical galleries. Unlike 
S. paucimobilis, the strain was positive 
for nitrate reductase and l-rhamnose. 
Also, negative reaction for urease and 
l-fucose  assimilation  differentiated 
the strain from S. thalpophilum. At the 
species level, the bacterium grew well 
at 37°C, unlike Chitinophaga arven-
sicola,  and  showed  positive  oxidase 
reaction and nitrate reduction, unlike 
Chitinophaga ginsengisegetis (2,5).
Disk diffusion tests showed that 
the  bacterium  was  multiresistant  to 
antimicrobial  drugs,  including  most 
of  the  β-lactams,  aminoglycosides, 
fluoroquinolones,  colistin,  fosfomy-
cin, and tigecyclin. It remained sus-
ceptible  to  amoxicillin-clavulanate, 
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ticarcillin-clavulanate,  carbapenems, 
and  trimethoprim-sulfamethoxazole. 
Interpretation of the susceptibility test 
was impossible before 48 hours incu-
bation, i.e., 4 days after the first posi-
tive blood culture.
We describe in this report a case 
of human bacteremia due to C. terrae. 
This environmental organism behav-
ing as an opportunistic pathogen was 
able to produce infection in a severe-
ly  immunosuppressed  woman.  The 
source of bacteremia was not clearly 
established.  Catheter-related  bacter-
emia was not confirmed by culture of 
the CVC tip sent to the laboratory on 
September  3.  Virulence  factors  con-
tributing  to  the  pathogenicity  of  C. 
terrae have not yet been well defined. 
The infection could have been favored 
by  the  immunosuppressive  therapy, 
the profound leukopenia, and the ex-
tensive cutaneous detachment subse-
quently associated with methotrexate 
overdose in this patient. Unlike most 
susceptible environmental organisms, 
this bacterium probably was assisted 
by  its  multiresistance  to  antimicro-
bial drugs in producing infection. The 
intrinsic or acquired resistance of C. 
terrae to antimicrobial drugs has not 
yet  been  fully  elucidated.  The  lack 
of commercially available biochemi-
cal  gallery  databases  makes  correct 
identification  of  this  environmental 
organism difficult. It also underlines 
the usefulness of 16S rDNA sequenc-
ing for identification of unusual gram-
negative bacilli isolated from immu-
nocompromised hosts (7).
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Figure 1 : 
Neighbor-joining  tree  showing  the  phylogenetic  placement  of  strain  NTS8639  (boldface) 
among members of the Chitinophaga terrae species. Twenty one 16S rRNA gene sequences 
selected  from  the  GenBank  database  were  aligned  with  that  of  strain  NTS8639  by  using 
Mega4 (http://www.megasoftware.net/). Accession numbers are indicated just behind species 
name. The evolutionary history was inferred using the Neighbor-Joining method. The optimal 
tree with the sum of branch length = 1.12829943 is shown. The percentage of replicate trees 
in  which  the  associated  taxa  clustered  together  in  the  bootstrap  test  (1000  replicates)  are 
shown next to the branches. The tree is drawn to scale, with branch lengths in the same units 
as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary 
distances were computed using the Kimura 2-parameter method and are in the units of the 
number of base substitutions per site. There were a total of 1304 positions in the final dataset. 
Phylogenetic  analyses  were  conducted  in  MEGA4.  Neighbor-joining  and  parsimony  trees 
were globally congruent with the distance tree and confirmed the placement of the strain 
NTS8639 in the Chitinophaga terrae species. The scale bar indicates 0.05 substitutions per 
nucleotide position. 
Figure.	Neighbor-joining	(NJ)	tree	showing	the	phylogenetic	placement	of	strain	NTS8639	(in	
boldface)	among	members	of	the	Chitinophaga terrae	species.	Twenty-one	16S	rRNA	gene	
sequences	selected	from	the	GenBank	database	were	aligned	with	that	of	strain	NTS8639	
by	 using	 MEGA4	 (www.megasoftware.net).	Accession	 numbers	 are	 indicated	 after	 the	
species	name.	The	evolutionary	history	was	inferred	using	the	NJ	method.	The	figure	shows	
the	optimal	tree;	the	sum	of	the	branch	lengths	=	1.12829943.	The	percentage	of	replicate	
trees	in	which	the	associated	taxa	clustered	together	in	the	bootstrap	test	(1,000	replicates)	
are	shown	next	to	the	branches.	The	tree	is	drawn	to	scale,	with	branch	lengths	in	the	
same	units	as	those	of	the	evolutionary	distances	used	to	infer	the	phylogenetic	tree.	The	
evolutionary	distances	were	computed	using	the	Kimura	2–parameter	method	and	are	in	the	
units	of	the	number	of	base	substitutions	per	site.	The	final	dataset	contains	1,304	positions.	
Phylogenetic	analyses	were	conducted	in	MEGA4.	NJ	and	parsimony	trees	were	globally	
congruent	with	the	distance	tree	and	confirmed	the	placement	of	the	strain	NTS8639	in	the	
C. terrae species.	Scale	bar	indicates	substitutions	per	nucleotide	position.